• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Supriya Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 75656.0
  • ISIN : INE07RO01027
724.00 -26 (-3.48%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    721.10

  • Today’s High

    758.45

  • Open

    751.60

  • Perv Close

    750.10

  • 52W Low

    330.00

  • 52W High

    842.00

Key Indicators

  • P/E(TTM)

    30.99

  • Mar.Cap (₹Cr.)

    5,826.95

  • Div & Yield %

    0.14

  • Book Value(₹)

    123.85

  • Debt-Equity Ratio

    -3.48

  • AGM Date

    30-May-2025

  • EPS

    23.35

  • P/E Ratio

    30.99

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    5,826.95

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.10

  • BV (₹)

    123.80

  • Sales( ₹ in Cr.)

    696.49

  • NP (in Cr.)

    187.96

  • NP Var(%)

    58.0

  • Div%

    50.0

  • CPS (₹)

    25.90

  • EPS (₹)

    23.40

  • Traded Value (₹ in Lakhs)

    5,823.33

  • 52 Week High

    842.00

  • 52 Week Low

    330.00

  • Price BSE

    724.0

  • Price NSE

    724.00

  • Market Capital( in Cr.)

    5,823.33

  • P/C Ratio

    28.00

  • P/E Ratio

    31.00

  • Price Vs.BV

    23.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 646.96 516.47 588.52 430.97 311.64 321.28
Excise Duty 76.59 55.53 58.47 39.76 0.00 43.44
Net Sales 570.37 460.94 530.05 391.21 311.64 277.84
Other Income 10.64 9.49 7.58 5.01 11.07 8.02
Stock Adjustments -30.31 6.51 3.03 12.44 13.90 -0.80
Total Income 550.70 476.94 540.66 408.66 336.61 285.06
EXPENDITURE :            
Raw Materials 191.43 187.32 198.83 140.57 152.38 146.07
Power and Fuel Cost 21.37 20.95 14.07 9.24 8.97 0.00
Employee Cost 67.64 55.58 49.08 32.76 18.88 0.00
Other Manufacturing Expenses 34.38 28.87 18.44 13.15 8.27 0.00
Selling and Administration Expenses 39.43 37.32 33.83 31.88 30.10 0.00
Miscellaneous Expenses 9.80 8.51 4.84 2.92 8.56 0.00
Employee Benefit Expenses 67.64 55.58 49.08 32.76 18.88 0.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 364.04 338.55 319.09 230.51 227.15 212.30
Operating Profit 186.65 138.38 221.56 178.15 109.45 72.76
Interest 5.15 3.08 4.20 4.08 6.85 10.22
Gross Profit 181.50 135.30 217.36 174.07 102.60 62.54
Depreciation 15.81 11.82 10.12 6.76 6.41 5.44
Profit Before Tax 165.69 123.48 207.24 167.31 96.19 57.10
Current Tax 37.10 30.68 52.19 43.02 25.07 17.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 9.48 2.95 3.25 0.69 -2.23 0.68
Reported Net Profit 119.11 89.86 151.81 123.59 73.35 39.42
Extraordinary Items 0.00 -0.08 0.00 0.00 0.00 0.00
Adjusted Net Profit 119.11 89.94 151.81 123.59 73.35 39.42
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -3.36 -0.29
P & L Balance brought forward 486.16 401.13 253.72 134.08 79.08 40.02
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.83 4.83 4.39 3.96 14.64 0.00
P & L Balance carried down 600.45 486.16 401.13 253.72 134.43 79.15
Dividend 0.00 0.00 0.00 0.00 14.64 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 40.00 30.00 30.00 27.00 100.00 0.00
Dividend Per Share(Rs) 0.80 0.60 0.60 0.54 10.00 0.00
Earnings Per Share-Unit Curr 14.80 11.16 18.86 16.89 50.11 5.39
Earnings Per Share(Adj)-Unit Curr 14.80 11.16 18.86 - - -
Book Value 101.31 86.91 76.50 36.70 101.84 12.82
Book Value(Adj)-Unit Curr 101.31 86.91 76.50 - - -

Shareholding Pattern

  • Promoter Group

    68.30%

  • Public Share Holding

    31.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10 0.00 10 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 54,967,815 68.30 54,967,815 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 54,967,825 68.30 54,967,825 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,785,898 7.19 5,785,898 78
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,371,829 1.70 1,371,829 2
Mutual Funds / UTI 528,694 0.66 528,694 8
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,526,597 1.90 1,526,597 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9,213,018 11.45 9,213,018 98
2] Non Institution
Bodies Corporate 1,205,807 1.50 1,205,807 384
Clearing Members 427 0.00 427 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 967,938 1.20 967,938 2,022
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 723,769 0.90 723,769 1,314
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 708,104 0.88 708,104 3
Individuals holding nominal share capital up to Rs. 1 lakh 12,491,341 15.52 12,491,341 87,156
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 330 0.00 330 2
Others 0 0.00 0 0
Sub Total 16,301,957 20.26 16,301,957 90,947
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 80,482,800 100.00 80,482,800 91,051

Company Background

Supriya Lifescience LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Supriya Lifescience Ltd
  • BSE Code : 75656.0
  • ISIN : INE07RO01027

  • Incorporation Year

    2008

  • Registered Office

    207/208 Udyog Bhavan
    Sonawala Road Goregaon (East), Mumbai,
    Maharashtra-400063

  • Telephone

    91-22-40332727

  • FAX

  • Chairman

    Satish Waman Wagh

  • Managing Director

    Shivani Satish Wagh

  • Company Secretary

    Prachi Sathe

  • Auditor

    Kakaria & Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Supriya Lifescience Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Supriya Lifesci. 723.55 581.01 646.96 30.99 22.05
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92